We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » EMA: Orphan Drug Designation Requests up 38 Percent in 2009
EMA: Orphan Drug Designation Requests up 38 Percent in 2009
May 20, 2010
Three-quarters of all applications for orphan drug designation submitted to the European Medicines Agency (EMA) last year were for drugs intended for the treatment of children, according to the agency’s 2009 annual report.